These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 28044264

  • 1. Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort.
    Levi M, Prayogi G, Sastranagara F, Sudianto E, Widjajahakim G, Gani W, Mahanadi A, Agnes J, Khairunisa BH, Utomo AR.
    J Gastrointest Cancer; 2018 Jun; 49(2):124-131. PubMed ID: 28044264
    [Abstract] [Full Text] [Related]

  • 2. Mutations in codons 12 and 13 of K-ras exon 2 in colorectal tumors of Saudi Arabian patients: frequency, clincopathological associations, and clinical outcomes.
    Zekri J, Al-Shehri A, Mahrous M, Al-Rehaily S, Darwish T, Bassi S, El Taani H, Al Zahrani A, Elsamany S, Al-Maghrabi J, Sadiq BB.
    Genet Mol Res; 2017 Feb 16; 16(1):. PubMed ID: 28218784
    [Abstract] [Full Text] [Related]

  • 3. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-ras gene in colorectal cancer patients and its association with liver metastases: Data from a South Asian country.
    Faleel FD, Zoysa MI, Lokuhetti MD, Gunawardena YI, Chandrasekharan VN, Dassanayake RS.
    J Cancer Res Ther; 2016 Feb 16; 12(4):1272-1277. PubMed ID: 28169239
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials.
    Peeters M, Kafatos G, Taylor A, Gastanaga VM, Oliner KS, Hechmati G, Terwey JH, van Krieken JH.
    Eur J Cancer; 2015 Sep 16; 51(13):1704-13. PubMed ID: 26049686
    [Abstract] [Full Text] [Related]

  • 5. Association of folate intake, dietary habits, smoking and COX-2 promotor -765G>C polymorphism with K-ras mutation in patients with colorectal cancer.
    Kamal MM, Youssef OZ, Lotfy AN, Elsaed ET, Fawzy MM.
    J Egypt Natl Canc Inst; 2012 Sep 16; 24(3):115-22. PubMed ID: 22929917
    [Abstract] [Full Text] [Related]

  • 6. Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.
    Yoshino T, Muro K, Yamaguchi K, Nishina T, Denda T, Kudo T, Okamoto W, Taniguchi H, Akagi K, Kajiwara T, Hironaka S, Satoh T.
    EBioMedicine; 2015 Apr 16; 2(4):317-23. PubMed ID: 26137573
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.
    Bai S, Feng Q, Pan XY, Zou H, Chen HB, Wang P, Zhou XL, Hong YL, Song SL, Yang JL.
    Int J Mol Med; 2017 Apr 16; 39(4):861-868. PubMed ID: 28259994
    [Abstract] [Full Text] [Related]

  • 8. Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.
    Jin M, Long ZW, Yang J, Lin X.
    Pathol Oncol Res; 2018 Jan 16; 24(1):45-57. PubMed ID: 28188432
    [Abstract] [Full Text] [Related]

  • 9. High-throughput screening of extended RAS mutations based on high-resolution melting analysis for prediction of anti-EGFR treatment efficacy in colorectal carcinoma.
    Ishige T, Itoga S, Sato K, Kitamura K, Nishimura M, Sawai S, Matsushita K, Suzuki K, Ota S, Miyauchi H, Matsubara H, Nakatani Y, Nomura F.
    Clin Biochem; 2014 Dec 16; 47(18):340-3. PubMed ID: 25262986
    [Abstract] [Full Text] [Related]

  • 10. Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?
    Allard MA, Saffroy R, de la Maisonneuve PB, Ricca L, Bosselut N, Hamelin J, Lecorche E, Bejarano MA, Innominato P, Sebagh M, Adam R, Morère JF, Lemoine A.
    Target Oncol; 2015 Sep 16; 10(3):415-21. PubMed ID: 25420993
    [Abstract] [Full Text] [Related]

  • 11. The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer: A National Study.
    Cárdenas-Ramos SG, Alcázar-González G, Reyes-Cortés LM, Torres-Grimaldo AA, Calderón-Garcidueñas AL, Morales-Casas J, Flores-Sánchez P, De León-Escobedo R, Gómez-Díaz A, Moreno-Bringas C, Sánchez-Guillén J, Ramos-Salazar P, González-de León C, Barrera-Saldaña HA.
    Am J Clin Oncol; 2017 Jun 16; 40(3):274-276. PubMed ID: 25333735
    [Abstract] [Full Text] [Related]

  • 12. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study.
    Brink M, de Goeij AF, Weijenberg MP, Roemen GM, Lentjes MH, Pachen MM, Smits KM, de Bruïne AP, Goldbohm RA, van den Brandt PA.
    Carcinogenesis; 2003 Apr 16; 24(4):703-10. PubMed ID: 12727799
    [Abstract] [Full Text] [Related]

  • 13. ["Field cancerization"--an additional phenomenon in development of colon tumors? K-ras codon 12 mutations in normal colonic mucosa of patients with colorectal neoplasms].
    Aivado M, Gynes M, Gorelov V, Schmidt WU, Röher HD, Goretzki PE.
    Chirurg; 2000 Oct 16; 71(10):1230-4; discussion 1234-5. PubMed ID: 11077584
    [Abstract] [Full Text] [Related]

  • 14. Relationship between expression of ras p21 oncoprotein and mutation status of the K-ras gene in sporadic colorectal cancer patients in Tunisia.
    Sammoud S, Khiari M, Semeh A, Amine L, Ines C, Amira A, Lilia K, Taher K, Sabeh M, Saadia B.
    Appl Immunohistochem Mol Morphol; 2012 Mar 16; 20(2):146-52. PubMed ID: 21768877
    [Abstract] [Full Text] [Related]

  • 15. [Clinicopathological characteristics, MSI and K-ras gene mutations of double primary malignancies associated with colorectal cancer].
    Li Q, Zhang B, Niu FN, Ye Q, Chen J, Fan XS.
    Zhonghua Yi Xue Za Zhi; 2020 Feb 04; 100(4):301-306. PubMed ID: 32075360
    [Abstract] [Full Text] [Related]

  • 16. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
    Gao J, Sun ZW, Li YY, Shen L.
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep 04; 41(9):579-83. PubMed ID: 23157823
    [Abstract] [Full Text] [Related]

  • 17. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing.
    Mack E, Stabla K, Riera-Knorrenschild J, Moll R, Neubauer A, Brendel C.
    BMC Cancer; 2016 Aug 02; 16():585. PubMed ID: 27485514
    [Abstract] [Full Text] [Related]

  • 18. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behavior.
    Jang S, Hong M, Shin MK, Kim BC, Shin HS, Yu E, Hong SM, Kim J, Chun SM, Kim TI, Choi KC, Ko YW, Kim JW.
    Hum Pathol; 2017 Jul 02; 65():21-30. PubMed ID: 28188750
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India.
    Veldore VH, Rao MR, Prabhudesai SA, Tejaswi R, Kakara S, Pattanayak S, Krishnamoorthy N, Tejaswini BN, Hazarika D, Gangoli A, Rahman SM, Dixit J, Naik R, Diwakar RB, Satheesh CT, Shashidhara HP, Patil S, Gopinath KS, Kumar BS.
    Indian J Cancer; 2014 Jul 02; 51(4):531-7. PubMed ID: 26842186
    [Abstract] [Full Text] [Related]

  • 20. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
    Karim B, Florence C, Kamel R, Nadia K, Ines O, Raja M, Sarra BJ, Florent S, Amel BA.
    Cancer Biomark; 2014 Jul 02; 8(6):331-40. PubMed ID: 22072121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.